<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>The consistency and value of immunotherapy</title>
  <description>This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called:  Immunotherapy offers survival extension for brain tumour patients and  The evolution of assays for immuno-oncology research. The first article looks into why data from a Phase III clinical trial offers promise for patients with a deadly form of brain cancer.&amp;amp;nbsp; The second article shares insight from Dr Shailendra Singh, Founder and CEO of Cellomatics Biosciences. </description>
  <author_name>The Drug Discovery World Podcast</author_name>
  <author_url>https://www.ddw-online.com/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/33121807/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/178287267</thumbnail_url>
</oembed>
